Chemed (CHE) Receivables (2009 - 2026)

Chemed's Receivables history runs 18 years deep, the most recent figure standing at $215.5 million for Q1 2026.

• In Q1 2026, Receivables fell 25.03% year-over-year to $215.5 million; the TTM figure through Mar 2026 stood at $215.5 million (down 25.03% YoY), while the FY2025 annual figure was $191.2 million, up 6.26% from the prior year.
• Receivables was $215.5 million for Q1 2026 at Chemed, up from $191.2 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $287.4 million in Q1 2025 to a low of $117.3 million in Q1 2022.
• Historically, Receivables has averaged $176.3 million across 5 years, with a median of $180.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Receivables soared 60.22% in 2025, then slipped 25.03% in 2026.
• A 5-year view of Receivables shows it stood at $141.2 million in 2022, then climbed by 29.7% to $183.2 million in 2023, then retreated by 1.76% to $180.0 million in 2024, then rose by 6.26% to $191.2 million in 2025, then increased by 12.68% to $215.5 million in 2026.
• The last three Receivables figures came in at $215.5 million (Q1 2026), $191.2 million (Q4 2025), and $223.7 million (Q3 2025), per Business Quant data.